00:00It's Benzinga bringing Wall Street to Main Street.
00:02CVS Health reported fourth quarter results that beat Wall Street estimates and reaffirmed its
00:072026 outlook as the company continued its turnaround, according to CNBC.
00:12CVS posted adjusted earnings of $1.09 per share on revenue of $105.69 billion,
00:20topping expectations. Net income rose to $2.92 billion, or $2.30 per share.
00:26The retail pharmacy chain reaffirmed full-year profit guidance of $7 to $7.20 per share and
00:33maintained 2026 revenue guidance of at least $400 billion. The outlook includes $20 billion in
00:40headwinds tied to its exit from the Affordable Care Act exchange market and lower drug prices.
00:45Growth was supported by Aetna, Caremark, and higher pharmacy volumes following
00:49Rite Aid prescription acquisitions. For all things money, visit Benzinga.com.
Comments